Eli Lilly said Wednesday it is suing six companies selling versions of its experimental weight-loss drug retatrutide, calling it the beginning of a concerted effort to crack down on a vast illicit market. Lilly’s chief medical officer said, “What is being sold on the black market is not a medicine…and not worth the risk.” #medicine #glp1